A dynamic map for learning, communicating, navigating and improving therapeutic development

Nature Reviews Drug Discovery

Volumn 17, Issue 2, 2018, Pages 150-152

  Wagner, John ^a   Dahlem, Andrew M ^b   Hudson, Lynn D ^c   Terry, Sharon F ^d   Altman, Russ B ^e   Gilliland, C Taylor ^f   Defeo, Christopher ^g   Austin, Christopher P ^f  

^a TAKEDA PHARMACEUTICALS   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c CRITICAL PATH INSTITUTE   (United States)

^d GENETIC ALLIANCE   (United States)

^e STANFORD UNIVERSITY   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g Georgetown Preparatory School   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

CLINICAL RESEARCH; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG INFORMATION; DRUG RESEARCH; DRUG UTILIZATION; LETTER; MEDICAL EDUCATION; PRIORITY JOURNAL; DRUG INDUSTRY; LEARNING;

DRUG INDUSTRY; LEARNING;

EID: 85041375294     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd.2017.217     Document Type: Letter

References (3)

1. Paul, S. M. et al. How to improve R&D productivity: The pharmaceutical industry's grand challenge. Nat. Rev. Drug Discov. 9, 203-214 (2010).
2. Baxter, K. et al. An end to the myth: There is no drug development pipeline. Sci. Transl Med. 5, 171cm1 (2013).
3. Wagner, J. A. et al. Application of a dynamic map for learning, communicating, navigating and improving therapeutic development. Clin. Transl Sci. (in the press; doi: 10. 1111/cts. 12531).